Results

Total Results: 51 records

Showing results for "colonoscopy".
Users also searched for: colon cancer

41. First Annual Report to Congress on High-Priority Evidence Gaps for Clinical Preventive Services (pdf file)
    www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/tfannrpt2011.pdf
    January 01, 2012 - smear to detect cervical cancer), services that are available through primary care referral (such as a colonoscopy … USPSTF recommends screening for colorectal cancer using fecal occult blood testing, sigmoidoscopy, or colonoscopy

42. Archived: Modeling Report: Lung Cancer: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/modeling-report/lung-cancer-screening-december-2013
    July 30, 2013 - breast cancer deaths averted), and the colorectal cancer recommendations would mean 225,000 screening colonoscopies

43. Benefits and Harms of Computed Tomography Lung Cancer Screening Programs for High Risk Populations (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/RkeQEwKRWULreuWecXG8S-
    July 01, 2013 - breast cancer deaths averted), and the colorectal cancer recommendations would mean 225,000 screening colonoscopies

44. Evidence Summary: Ovarian Cancer: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/ovarian-cancer-screening
    February 13, 2018 - lung, colorectal, or ovarian cancer; current treatment for cancer other than nonmelanoma skin cancer; colonoscopy

45. Archived: Decision Analysis: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/decision-analysis-for-aspirin/aspirin-to-prevent-cardiovascular-disease-and-cancer-april-2016
    April 11, 2016 - are derived from U.S. data 49 , 50 and reflect contemporary use of screening technologies, such as colonoscopy

46. Aspirin for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: A Decision Analysis for the USPSTF (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/_SfjkGNHBnLqn8ySe7kAdg
    April 01, 2016 - are derived from U.S. data (49, 50) and reflect contemporary use of screening technologies, such as colonoscopy

47. Second Annual Report to Congress on High-Priority Evidence Gaps for Clinical Preventive Services (pdf file)
    www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/annlrpt2012%20(2).pdf
    November 01, 2012 - USPSTF recommends screening for colorectal cancer using fecal occult blood testing, sigmoidoscopy, or colonoscopy

48. High-Priority Evidence Gaps for Clinical Preventive Services Improving the Health of Women Through Research (pdf file)
    www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/2015annlrpt%20(4)_0.pdf
    January 01, 2016 - USPSTF recommends screening for colorectal cancer with fecal occult blood testing, sigmoidoscopy, or colonoscopy

49. High-Priority Evidence Gaps for Clinical Preventive Services Improving the Health of Women Through Research (pdf file)
    www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/2015annlrpt%20(4).pdf
    January 01, 2016 - USPSTF recommends screening for colorectal cancer with fecal occult blood testing, sigmoidoscopy, or colonoscopy

50. High-Priority Evidence Gaps for Clinical Preventive Services Fourth Annual Report to Congress (pdf file)
    www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/annlrpt2014%20(6).pdf
    November 01, 2014 - USPSTF recommends screening for colorectal cancer with fecal occult blood testing, sigmoidoscopy, or colonoscopy

51. High-Priority Evidence Gaps for Clinical Preventive Services Fourth Annual Report to Congress (pdf file)
    www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/annlrpt2014%20(9).pdf
    November 01, 2014 - USPSTF recommends screening for colorectal cancer with fecal occult blood testing, sigmoidoscopy, or colonoscopy